<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260425069157N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-25</date_registration>
      <primary_sponsor>Oroumia University of Medical Sciences</primary_sponsor>
      <public_title>Evaluating the effect of left lateral tilt before and after spinal anesthesia on hemodynamic status of mothers undergoing elective cesarean section</public_title>
      <acronym></acronym>
      <scientific_title>Comparision of hemodynamic effect in lateral tilt before and after spinal anesthesia during elective</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>110</target_size>
      <recruitment_status>Pending</recruitment_status>
      <url>https://irct.ir/trial/94197</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: This is a parallel-group, randomized clinical trial that compares hemodynamic parameters between the two study groups at baseline and every 5 minutes until the end of surgery. The intervention consists of a positioning maneuver (applying a left lateral tilt before or after spinal anesthesia), Randomization description: Participants will be allocated to the intervention and control groups using block randomization with block sizes of 4 and 6 on an individual basis. Stratified randomization is not used. The random sequence will be generated using Random Allocation Software. To ensure allocation concealment, sequentially numbered, opaque, sealed envelopes (SNOSE) will be utilized. Upon obtaining written informed consent and arrival in the operating room, the envelope corresponding to the patient’s number will be opened by an individual independent of the principal investigator to determine the intervention type (left lateral tilt before or after spinal anesthesia), Blinding description: This study is a double-blind randomized clinical trial. Due to the physical nature of the intervention (positioning tilt), blinding the patients and the attending anesthesiologist was not feasible. However, to minimize bias, both the outcome assessor (who recorded hemodynamic parameters without knowledge of group allocation timing) and the data analyst (who analyzed coded datasets as groups A and B) were blinded to group allocations.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hypotension and bradycardia induced by spinal anesthesia during elective cesarean section.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group1: Application of a 15° left lateral tilt before spinal anesthesia. Intervention 2: Intervention group2: Application of a 15° left lateral tilt after spinal anesthesia.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I will make a decision to publish after the completion of the project and according to the results</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Roghayea Neisari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kosar Comprehensive Women’s Educational and Medical Center., Hasani Street., Urmia</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5715859497</zip>
        <telephone>+98 44 3346 0998</telephone>
        <email>nisari.r@umsu.ac.ir</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Roghayea Neisari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kosar Comprehensive Women’s Educational and Medical Center., Hasani Street., Urmia</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5715859497</zip>
        <telephone>+98 44 3346 0998</telephone>
        <email>nisari.r@umsu.ac.ir</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 18 and 40 years
Term pregnancy (37-40 weeks of gestation)
Candidate for elective (non-emergency) cesarean section
Singleton pregnancy
ASA physical status I or II
Written informed consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of known cardiovascular diseases or chronic hypertension
Severe/morbid obesity (Body Mass Index [BMI] &gt; 40 kg/m²)
Preeclampsia or eclampsia
Known history of allergy to local anesthetics
Active bleeding
Coagulation disorders (coagulopathy)
Conversion or need for general anesthesia</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O29.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Central nervous system complications of anesthesia during pregnancy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group1: Application of a 15° left lateral tilt before spinal anesthesia</i_keyword>
      <i_keyword>Intervention group2: Application of a 15° left lateral tilt after spinal anesthesia</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Systolic Blood Pressure). Timepoint: Baseline (pre-intervention) and every 5 minutes until the end of surgery. Method of measurement: Standard operating room vital signs monitor.</prim_outcome>
      <prim_outcome>Diastolic Blood Pressure. Timepoint: Baseline (pre-intervention) and every 5 minutes until the end of surgery. Method of measurement: Standard operating room vital signs monitor.</prim_outcome>
      <prim_outcome>Mean Arterial Pressure (MAP). Timepoint: Baseline (pre-intervention) and every 5 minutes until the end of surgery. Method of measurement: Standard operating room monitor.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Heart Rate. Timepoint: Baseline (pre-intervention) and every 5 minutes until the end of surgery. Method of measurement: Standard monitor (ECG / Pulse Oximetry).</sec_outcome>
      <sec_outcome>Incidence of Hypotension. Timepoint: From the onset of spinal anesthesia until the end of surgery. Method of measurement: Recorded via checklist; defined as a decrease of more than 20% from baseline blood pressure.</sec_outcome>
      <sec_outcome>Incidence of Bradycardia. Timepoint: From the onset of spinal anesthesia until the end of surgery. Method of measurement: Recorded via checklist; defined as a decrease of more than 20% from baseline heart rate.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Oroumia University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-09-16</approval_date>
        <contact_name>Research Ethics Committees of Urmia University of Medical Sciences</contact_name>
        <contact_address>Urmia University of Medical Sciences., Emergency Alley., Resalat Boulevard., Urmia Urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
